1 |
2,2-bis(4-hydroxy-3-tert-butylphenyl)propane
| 0件: | - | - | - | 5件: 19 19, 86, 90, 276, 299 |
2 |
Acetamide
| 1件: Acetamide Acetamide | - | - | - | 2件: 86 86, 154 |
3 |
Acetaminophen
| 4件: Acetaminophen Acetaminophen; Paracetamol; Tylenol; Ultracet | 1件: D00217
D00217
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 15件: 3 3, 6, 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 |
4 |
Acetate
| 1件: Acetate Acetate | - | - | - | 41件: 1 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299 |
5 |
Acetazolamide
| 1件: Acetazolamide Acetazolamide | 1件: D00218
D00218
| 13件: CA1 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 | 7件: Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
6 |
Acetic acid C-11
| 1件: 11C-ACETATE 11C-ACETATE | - | - | - | 4件: 6 6, 13, 86, 88 |
7 |
Acetylsalicylic acid
| 2件: ACETYLSALICYLIC ACID ACETYLSALICYLIC ACID; Aspirin | 1件: D00109
D00109
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 14件: 13 13, 22, 46, 49, 51, 58, 64, 86, 97, 113, 158, 210, 231, 251 |
8 |
Activated charcoal
| 1件: Carbon Carbon | - | - | - | 6件: 6 6, 85, 86, 96, 97, 158 |
9 |
Albendazole
| 2件: Albendazole Albendazole; Eskazole | 1件: D00134
D00134
| - | - | 12件: 5 5, 6, 7, 13, 28, 51, 67, 86, 96, 97, 114, 127 |
10 |
Alunacedase alfa
| 1件: Recombinant Human Angiotensin-Converting Enzyme 2 Recombinant Human Angiotensin-Converting Enzyme 2 | - | - | - | 1件: 86 86 |
11 |
Ambrisentan
| 3件: Ambrisentan Ambrisentan; Letairis; Volibris | 1件: D07077
D07077
| 1件: EDNRA EDNRA 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 7件: 51 51, 84, 85, 86, 88, 210, 211 |
12 |
Aminohippuric acid
| 1件: Aminohippurate Aminohippurate | 1件: D06890
D06890
| - | - | 4件: 49 49, 53, 67, 86 |
13 |
Anakinra
| 2件: ANAKINRA ANAKINRA; KINERET | 1件: D02934
D02934
| 2件: IL1R1 IL1R1, IL1R2 💬 | 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 18件: 2 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 |
14 |
Anastrozole
| 2件: ANASTROZOLE ANASTROZOLE; Arimidex | 1件: D00960
D00960
| 1件: CYP19A1 CYP19A1 💬 | 3件: Metabolic pathways Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬 | 3件: 78 78, 86, 193 |
15 |
Angiotensin II
| 2件: Angiotensin Angiotensin; Angiotensin II | 2件: D00150
D00150
,
D02014
| 2件: AGTR1 AGTR1, AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 7件: 17 17, 19, 46, 66, 86, 222, 224 |
16 |
Apabetalone
| 1件: Apabetalone Apabetalone | 1件: D11131
D11131
| 4件: BRD2 BRD2, BRD3, BRD4, BRDT 💬 | - | 1件: 86 86 |
17 |
Aspartame
| 0件: | 1件: D02381
D02381
| 2件: TAS1R2 TAS1R2, TAS1R3 💬 | 2件: Carbohydrate digestion and absorption Carbohydrate digestion and absorption, Taste transduction 💬 | 4件: 6 6, 13, 67, 86 |
18 |
AV-101
| 1件: AV-101 AV-101 | - | - | - | 2件: 6 6, 86 |
19 |
Aviptadil
| 1件: Aviptadil Aviptadil | 1件: D12127
D12127
| - | - | 5件: 49 49, 51, 84, 85, 86 |
20 |
Bardoxolone
| 1件: Bardoxolone Bardoxolone | 1件: D09584
D09584
| - | - | 7件: 66 66, 67, 84, 85, 86, 218, 222 |
21 |
Bardoxolone methyl
| 1件: Bardoxolone methyl Bardoxolone methyl | 1件: D09585
D09585
| - | - | 7件: 66 66, 67, 84, 85, 86, 218, 222 |
22 |
Benzbromarone
| 1件: BENZBROMARONE BENZBROMARONE | 1件: D01056
D01056
| 1件: SLC22A12 SLC22A12 💬 | - | 1件: 86 86 |
23 |
Beraprost
| 1件: Beraprost Beraprost | 1件: D02720
D02720
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
24 |
BIA
| 1件: BIA BIA | - | - | - | 2件: 6 6, 86 |
25 |
Bisoprolol
| 2件: Bisoprolol Bisoprolol; Bisoprolol Fumarate | 1件: D02342
D02342
| 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 58 58, 67, 86, 113 |
26 |
Bosentan
| 2件: BOSENTAN BOSENTAN; TRACLEER | 2件: D01227
D01227
,
D07538
| 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 10件: 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
27 |
Capsaicin
| 2件: Capsaicin Capsaicin; Qutenza | 1件: D00250
D00250
| 1件: TRPV1 TRPV1 💬 | 2件: Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 3件: 6 6, 86, 226 |
28 |
Captopril
| 1件: Captopril Captopril | 1件: D00251
D00251
| 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 8件: 6 6, 17, 46, 86, 96, 97, 107, 271 |
29 |
Carbon monoxide
| 1件: Carbon Monoxide Carbon Monoxide | 1件: D09706
D09706
| - | - | 4件: 13 13, 53, 85, 86 |
30 |
Carvedilol
| 1件: Carvedilol Carvedilol | 1件: D00255
D00255
| 5件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 | 13件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 57 57, 86, 113, 210 |
31 |
Cetuximab
| 2件: Cetuximab Cetuximab; Erbitux | 1件: D03455
D03455
| 1件: EGFR EGFR 💬 | 48件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis 💬 | 2件: 51 51, 86 |
32 |
Chlorhexidine
| 2件: Chlorhexidine Chlorhexidine; Chlorhexidine Gluconate | 1件: D07668
D07668
| - | - | 2件: 86 86, 299 |
33 |
Cicletanine
| 1件: Cicletanine Cicletanine | 1件: D03487
D03487
| - | - | 1件: 86 86 |
34 |
Citrulline
| 1件: Citrulline Citrulline | - | - | - | 2件: 86 86, 113 |
35 |
Clopidogrel
| 1件: Clopidogrel Clopidogrel | 3件: D07729
D07729
,
D10823
,
D10824
| 1件: P2RY12 P2RY12 💬 | 1件: Platelet activation Platelet activation 💬 | 3件: 49 49, 51, 86 |
36 |
Conivaptan
| 1件: Conivaptan Conivaptan | 1件: D07748
D07748
| 2件: AVPR1A AVPR1A, AVPR2 💬 | 5件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬 | 1件: 86 86 |
37 |
CXA-10
| 1件: CXA-10 CXA-10 | - | - | - | 2件: 86 86, 222 |
38 |
D-glucose
| 2件: D-glucose D-glucose; Glucose | 1件: D00009
D00009
| - | - | 3件: 49 49, 86, 88 |
39 |
Dapagliflozin
| 2件: Dapagliflozin Dapagliflozin; Forxiga | 1件: D08897
D08897
| 1件: SLC5A2 SLC5A2 💬 | - | 7件: 19 19, 49, 66, 67, 86, 88, 222 |
40 |
Dextrose, unspecified form
| 3件: Dextrose Dextrose; Glucose; Smofkabiven | - | - | - | 16件: 2 2, 6, 13, 49, 50, 60, 65, 66, 70, 86, 88, 96, 97, 226, 257, 299 |
41 |
Dichloroacetic acid
| 1件: Dichloroacetate Dichloroacetate | - | - | - | 1件: 86 86 |
42 |
Diltiazem
| 2件: Diltiazem Diltiazem; Diltiazem Hydrochloride | 1件: D07845
D07845
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 51 51, 58, 86 |
43 |
Dimethyl fumarate
| 3件: Dimethyl fumarate Dimethyl fumarate; Dimethylfumarat; TECFIDERA | 1件: D03846
D03846
| 1件: KEAP1 KEAP1 💬 | 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 5件: 13 13, 49, 51, 86, 296 |
44 |
Diphenhydramine
| 2件: Diphenhydramine Diphenhydramine; Diphenhydramine hydrochloride | 1件: D00300
D00300
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 8件: 11 11, 13, 49, 51, 70, 86, 222, 256 |
45 |
Dobutamine
| 2件: Dobutamin Dobutamin; Dobutamine | 1件: D03879
D03879
| 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 57 57, 58, 86, 215 |
46 |
Elafin
| 1件: Elafin Elafin | - | - | - | 1件: 86 86 |
47 |
Epicatechin
| 1件: Epicatechin Epicatechin | - | - | - | 2件: 86 86, 113 |
48 |
Epoprostenol
| 6件: EPOPROSTENOL EPOPROSTENOL; Epoprostenol for injection; EPOPROSTENOL SODIUM; Flolan; Prostacyclin; Veletri | 1件: D00106
D00106
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
49 |
Esomeprazole
| 3件: Esomeprazole Esomeprazole; Nexium; Omeprazole | 1件: D07917
D07917
| 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 8件: 13 13, 46, 86, 98, 107, 113, 298, 299 |
50 |
Famotidine
| 2件: FAMOTIDINA FAMOTIDINA; Famotidine | 1件: D00318
D00318
| 1件: HRH2 HRH2 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬 | 6件: 6 6, 46, 61, 86, 98, 107 |
51 |
Ferric carboxymaltose
| 1件: FERRIC CARBOXYMALTOSE FERRIC CARBOXYMALTOSE | 1件: D08920
D08920
| - | - | 4件: 86 86, 96, 97, 299 |
52 |
Fluoxetine
| 5件: Fluoxetin Fluoxetin; FLUOXETINE; FLUOXETINE HYDROCHLORIDE; Fluoxétine; PROZAC | 1件: D00326
D00326
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 6件: 13 13, 17, 78, 86, 179, 206 |
53 |
Fulvestrant
| 2件: Faslodex Faslodex; Fulvestrant | 1件: D01161
D01161
| 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 2件: 49 49, 86 |
54 |
Furosemide
| 2件: Furosemide Furosemide; Furosemide Injection | 1件: D00331
D00331
| 1件: SLC12A2 SLC12A2 💬 | 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 2件: 6 6, 86 |
55 |
Gadobenic acid
| 2件: Gadobenate Gadobenate; MultiHance | 1件: D08018
D08018
| - | - | 3件: 13 13, 86, 88 |
56 |
Glycine
| 1件: Glycine Glycine | 1件: D00011
D00011
| - | - | 5件: 35 35, 60, 86, 226, 299 |
57 |
Gold
| 1件: Gold Gold | - | - | - | 43件: 2 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 167, 171, 193, 218, 222, 224, 226, 227, 230, 271, 291, 296, 298, 310, 318 |
58 |
GSK2256098
| 1件: GSK2256098 GSK2256098 | - | - | - | 1件: 86 86 |
59 |
Hydroxyurea
| 1件: Hydroxyurea Hydroxyurea | 1件: D00341
D00341
| 1件: RRM2 RRM2 💬 | 7件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬 | 8件: 3 3, 13, 19, 20, 65, 85, 86, 284 |
60 |
Iloprost
| 2件: ILOPROST ILOPROST; Ventavis | 1件: D02721
D02721
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 4件: 51 51, 84, 85, 86 |
61 |
Imatinib
| 4件: Gleevec Gleevec; GLIVEC; Imatinib; Imatinib Mesylate | 1件: D08066
D08066
| 3件: ABL1 ABL1, KIT, PDGFRA 💬 | 32件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 12件: 13 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 |
62 |
Ipratropium
| 1件: Ipratropium Ipratropium | - | - | - | 2件: 6 6, 86 |
63 |
Iron Dextran
| 1件: Iron Dextran Iron Dextran | 1件: D02141
D02141
| - | - | 4件: 62 62, 86, 96, 97 |
64 |
Iron polymaltose
| 1件: Fusion Fusion | - | - | - | 9件: 11 11, 13, 46, 49, 69, 70, 86, 271, 299 |
65 |
Levocarnitine
| 4件: Carnitine Carnitine; L-Carnitine; Levocarnitine; Xyzal | 1件: D02176
D02176
| - | - | 11件: 3 3, 5, 13, 53, 58, 86, 96, 97, 265, 298, 316 |
66 |
Lidocaine
| 4件: Aloe Aloe; Lidocaine; Lignocaine; Xylocaine | 2件: D00358
D00358
,
D08127
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 13件: 6 6, 13, 22, 34, 46, 51, 70, 84, 86, 107, 168, 226, 256 |
67 |
Lisuride
| 1件: LISURIDE LISURIDE | 1件: D08132
D08132
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 86 |
68 |
Macitentan
| 2件: MACITENTAN MACITENTAN; Opsumit | 1件: D10135
D10135
| 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 51 51, 85, 86, 88, 210 |
69 |
Medical air
| 1件: Medical air Medical air | - | - | - | 4件: 85 85, 86, 97, 193 |
70 |
Metformin
| 5件: Metformin Metformin; Metformin HCl; METFORMIN HYDROCHLORIDE; METFORMINA; Metformine | 1件: D04966
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 25件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301 |
71 |
Methylprednisolone
| 4件: Medrol Medrol; Methylprednisolon; Methylprednisolone; Methylprednisolone acetate | 1件: D00407
D00407
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 46件: 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 |
72 |
Morphine
| 2件: Morphine Morphine; MORPHINE SULFATE | 1件: D08233
D08233
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 5件: 36 36, 46, 70, 85, 86 |
73 |
Moxifloxacin
| 2件: Moxifloxacin Moxifloxacin; Moxifloxacin hydrochloride | 1件: D08237
D08237
| - | - | 9件: 2 2, 6, 46, 49, 85, 86, 113, 240, 299 |
74 |
Nicardipine
| 1件: Nicardipine Nicardipine | 1件: D08270
D08270
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 70 70, 86 |
75 |
Nilotinib
| 2件: Nilotinib Nilotinib; TASIGNA | 1件: D08953
D08953
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | 33件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 5件: 6 6, 8, 34, 51, 86 |
76 |
Nitric Oxide
| 3件: INOmax INOmax; Nitric Oxide; Nitrosyl | 1件: D00074
D00074
| - | - | 12件: 6 6, 58, 85, 86, 88, 97, 210, 222, 251, 294, 299, 321 |
77 |
Nitrite
| 1件: Nitrite Nitrite | - | - | - | 2件: 58 58, 86 |
78 |
Olaparib
| 1件: Olaparib Olaparib | 1件: D09730
D09730
| 2件: PARP1 PARP1, PARP2 💬 | 5件: Apoptosis Apoptosis, Base excision repair, Diabetic cardiomyopathy, NF-kappa B signaling pathway, Necroptosis 💬 | 2件: 86 86, 285 |
79 |
Oxygen
| 3件: Medical air Medical air; Nitrogen; Oxygen | 1件: D00003
D00003
| - | - | 13件: 6 6, 49, 70, 85, 86, 88, 90, 96, 168, 193, 271, 299, 330 |
80 |
Pentoxifylline
| 1件: Pentoxifylline Pentoxifylline | 1件: D00501
D00501
| - | - | 12件: 26 26, 56, 84, 86, 93, 96, 97, 113, 220, 222, 296, 298 |
81 |
PF-00489791
| 1件: PF-00489791 PF-00489791 | - | - | - | 1件: 86 86 |
82 |
Pioglitazone
| 1件: Pioglitazone Pioglitazone | 1件: D08378
D08378
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 17件: 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
83 |
Placental Mesenchymal Stem Cells
| 2件: Placental Mesenchymal Stem Cells Placental Mesenchymal Stem Cells; PLX-PAD | - | - | - | 2件: 86 86, 118 |
84 |
Prasterone
| 3件: Dehydroepiandrosterone Dehydroepiandrosterone; DHEA; Prasterone | 1件: D08409
D08409
| 3件: AR AR, ESR1, ESR2 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 6件: 49 49, 53, 83, 86, 96, 113 |
85 |
Prednisone
| 3件: Prednisona Prednisona; PREDNISONE; RAYOS | 1件: D00473
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 45件: 2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 |
86 |
Ralinepag
| 1件: RALINEPAG RALINEPAG | 1件: D10725
D10725
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
87 |
Ranolazine
| 3件: RANEXA RANEXA; Ranolazina; Ranolazine | 1件: D05700
D05700
| - | - | 6件: 2 2, 58, 86, 96, 113, 114 |
88 |
Rifampicin
| 2件: Rifampicin Rifampicin; Rifampin | 1件: D00211
D00211
| - | - | 9件: 6 6, 13, 17, 46, 84, 86, 93, 299, 338 |
89 |
Riociguat
| 2件: Adempas Adempas; Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 6件: 51 51, 84, 86, 88, 225, 299 |
90 |
Ritonavir
| 2件: Norvir Norvir; Ritonavir | 1件: D00427
D00427
| - | - | 3件: 2 2, 86, 265 |
91 |
Rituximab
| 6件: MabThera MabThera; Rituxan; Rituximab; Rixathon; Ruxience; TRUXIMA | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 48件: 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
92 |
Salbutamol
| 3件: Albuterol Albuterol; Salbutamol; Ventolin | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 12件: 3 3, 11, 12, 13, 49, 85, 86, 89, 111, 113, 256, 299 |
93 |
Sapropterin
| 5件: 6R-BH4 6R-BH4; KUVAN; Sapropterin; SAPROPTERIN DIHYDROCHLORIDE; Tetrahydrobiopterin | 1件: D08505
D08505
| - | - | 5件: 51 51, 86, 124, 240, 299 |
94 |
Saquinavir
| 1件: Saquinavir Saquinavir | 1件: D00429
D00429
| - | - | 2件: 86 86, 265 |
95 |
Satralizumab
| 3件: Enspryng Enspryng; Sapelizumab; Satralizumab | 1件: D11079
D11079
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 3件: 11 11, 13, 86 |
96 |
Selexipag
| 2件: SELEXIPAG SELEXIPAG; Uptravi | 1件: D09994
D09994
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 5件: 51 51, 70, 84, 86, 88 |
97 |
Selonsertib
| 1件: Selonsertib Selonsertib | 1件: D10988
D10988
| 1件: MAP3K5 MAP3K5 💬 | 20件: Alcoholic liver disease Alcoholic liver disease, Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Huntington disease, Lipid and atherosclerosis, MAPK signaling pathway, Neurotrophin signaling pathway, Non-alcoholic fatty liver disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Protein processing in endoplasmic reticulum, Sphingolipid signaling pathway, Spinocerebellar ataxia, TNF signaling pathway, Thermogenesis, Tight junction 💬 | 1件: 86 86 |
98 |
Serine
| 2件: L-Serine L-Serine; Serine | 1件: D00016
D00016
| - | - | 4件: 2 2, 6, 86, 96 |
99 |
Sildenafil
| 6件: Mysildecard Mysildecard; Revatio; Sildenafil; Sildenafil Citrate; SILDENAFILO; Viagra | 1件: D08514
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 17件: 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 |
100 |
Simvastatin
| 3件: Simvastatin Simvastatin; Simvastatina; Simvastatine | 1件: D00434
D00434
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 21件: 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 |
101 |
Sirolimus
| 3件: RAPAMUNE RAPAMUNE; Rapamycin; Sirolimus | 1件: D00753
D00753
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 40件: 2 2, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 |
102 |
Sitaxentan
| 3件: Sitaxentan Sitaxentan; Sitaxsentan; Thelin | 1件: D07171
D07171
| 1件: EDNRA EDNRA 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
103 |
Sodium dichloroacetate
| 1件: Dichloroacetate Sodium Dichloroacetate Sodium | 1件: D05857
D05857
| 3件: PDK2 PDK2, PDK3, PDK4 💬 | 1件: Diabetic cardiomyopathy Diabetic cardiomyopathy 💬 | 1件: 86 86 |
104 |
Sorafenib
| 2件: Nexavar Nexavar; Sorafenib | 1件: D08524
D08524
| 8件: BRAF BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬 | 89件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 2件: 34 34, 86 |
105 |
Sotatercept
| 1件: Sotatercept Sotatercept | 1件: D09670
D09670
| 1件: ACVR2A ACVR2A 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | 2件: 86 86, 284 |
106 |
Spironolactone
| 1件: Spironolactone Spironolactone | 1件: D00443
D00443
| 1件: NR3C2 NR3C2 💬 | 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 8件: 46 46, 58, 67, 86, 113, 210, 218, 225 |
107 |
Sulfasalazine
| 3件: Salazosulfapyridine Salazosulfapyridine; Salicylazosulfapyridine; SULFASALAZINE | 1件: D00448
D00448
| - | - | 6件: 46 46, 86, 94, 107, 270, 271 |
108 |
Sulfate ion
| 1件: Sulfate Sulfate | - | - | - | 27件: 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 85, 86, 96, 111, 218, 222, 224, 226, 265, 296, 297, 299 |
109 |
Tadalafil
| 4件: Adcirca Adcirca; CIALIS; TADALAFIL; TADALAFILO | 1件: D02008
D02008
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 7件: 6 6, 51, 75, 84, 86, 113, 210 |
110 |
Terguride
| 1件: Terguride Terguride | 1件: D01348
D01348
| 2件: DRD2 DRD2, PRL 💬 | 12件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 51 51, 86 |
111 |
Tezosentan
| 1件: Tezosentan Tezosentan | - | - | - | 1件: 86 86 |
112 |
Threonine
| 1件: Threonine Threonine | 1件: D00041
D00041
| - | - | 2件: 86 86, 97 |
113 |
Tocilizumab
| 3件: ACTEMRA ACTEMRA; ROACTEMRA; TOCILIZUMAB | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 21件: 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 |
114 |
Tolvaptan
| 3件: Jinarc Jinarc; Samsca; TOLVAPTAN | 1件: D01213
D01213
| 1件: AVPR2 AVPR2 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 4件: 67 67, 72, 86, 225 |
115 |
Treprostinil
| 4件: Remodulin Remodulin; Treprostinil; Treprostinilo; Tyvaso | 1件: D06213
D06213
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 6件: 51 51, 84, 85, 86, 88, 210 |
116 |
Trimetazidine
| 1件: Trimetazidine Trimetazidine | 1件: D08642
D08642
| - | - | 3件: 2 2, 58, 86 |
117 |
Tyrosine
| 4件: Alanine Alanine; L-Tyrosine; Propanoic acid; Tyrosine | 1件: D00022
D00022
| - | - | 5件: 6 6, 75, 86, 111, 298 |
118 |
Ubenimex
| 1件: Ubenimex Ubenimex | 1件: D00087
D00087
| 1件: ANPEP ANPEP 💬 | 4件: Glutathione metabolism Glutathione metabolism, Hematopoietic cell lineage, Metabolic pathways, Renin-angiotensin system 💬 | 1件: 86 86 |
119 |
Ubidecarenone
| 3件: Coenzyme Q-10 Coenzyme Q-10; Coenzyme Q10; CoQ10 | 1件: D01065
D01065
| - | - | 12件: 2 2, 5, 6, 8, 10, 18, 46, 57, 86, 113, 214, 215 |
120 |
Udenafil
| 1件: Udenafil Udenafil | 1件: D10027
D10027
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 210 |
121 |
Ularitide
| 1件: ULARITIDE ULARITIDE | - | - | - | 1件: 86 86 |
122 |
Vardenafil
| 3件: Levitra Levitra; Vardenafil; Vardenafilo | 1件: D08668
D08668
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 3件: 13 13, 86, 299 |
123 |
Warfarin
| 2件: Warfarin Warfarin; Warfarin Sodium | 1件: D08682
D08682
| 2件: NQO1 NQO1, VKORC1 💬 | 7件: Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 11件: 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91 |
124 |
Zamicastat
| 1件: ZAMICASTAT ZAMICASTAT | - | - | - | 1件: 86 86 |